The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
The addition of cycles of irinotecan/temozolomide (i/T) to cycles of vincristine, doxorubicin, cyclophosphamide (VDC) and cycles of ifosfamide, etoposide (IE) for the treatment of Ewing sarcoma (ES).
 
Paul A. Meyers
Stock and Other Ownership Interests - Amgen; Bayer; EI Dupont; Henry Schein; Jazz Pharmaceuticals; Mednax; Novartis; Procter & Gamble; Sigma-Aldrich
Honoraria - France Foundation (I)
Consulting or Advisory Role - Astellas Pharma; Boehringer Ingelheim (I); Lilly
Speakers' Bureau - France Foundation (I); Genentech/Roche (I)
Travel, Accommodations, Expenses - InterMune (I); Takeda
 
Srikanth R. Ambati
No Relationships to Disclose
 
Emily Kanaya Slotkin
No Relationships to Disclose
 
Filemon Dela Cruz
No Relationships to Disclose
 
Leonard H. Wexler
Consulting or Advisory Role - AstraZeneca